Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated DsDNA release and AIM2 inflammasome activation
Yes, Glutathione is known for its detoxifying properties
Understanding this genetic profile helps you and your healthcare provider decide whether continuous therapy, periodic restart cycles, or combination approaches best fit your biology